文献
J-GLOBAL ID:201702287160700189
整理番号:17A0299741
FS CVIIIによるH sp90の標的化はEGFR変異肺非小細胞癌細胞におけるgefitinlb抵抗性を回避する【Powered by NICT】
Targeting Hsp90 with FS-108 circumvents gefitinlb resistance in EGFR mutant non-small cell lung cancer cells
著者 (12件):
Wang Yueqin
(Department of New Drug Screening Center, China Pharmaceutical University)
,
Shen Aijun
(Division of Anti-tumor Pharmacology,Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
,
Sun Jingya
(Division of Anti-tumor Pharmacology,Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
,
Wang Xin
(Division of Anti-tumor Pharmacology,Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
,
Liu Hongchun
(Division of Anti-tumor Pharmacology,Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
,
Zhang Minmin
(Division of Anti-tumor Pharmacology,Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
,
Chen Danqi
(Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
,
Xiong Bing
(Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
,
Shen Jingkang
(Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
,
Geng Meiyu
(Division of Anti-tumor Pharmacology,Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
,
Zheng Min
(Department of Thoracic Surgery, Shanghai Tongren Hospital, Shanghai Jlao Tong University School of Medicine)
,
Ding Jian
(Division of Anti-tumor Pharmacology,Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
資料名:
Acta Pharmacologica Sinica
(Acta Pharmacologica Sinica)
巻:
37
号:
12
ページ:
1587-1596
発行年:
2016年
JST資料番号:
C0089D
ISSN:
1671-4083
CODEN:
APSCG5
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
中国 (CHN)
言語:
英語 (EN)